LEADER 03136oam 2200505z 450 001 9910702867803321 005 20240402174012.0 010 $a1-280-35930-7 010 $a1-59259-891-9 010 $a9786610359301 010 $a9781592598915 024 7 $a10.1385/1592598919 035 $a(CKB)1000000000460712 035 $a(EXLCZ)991000000000460712 100 $a20240129d2005uuuu my 0 101 0 $aeng 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAttention Deficit Hyperactivity Disorder $eFrom Genes to Patients /$fEdited by David Gozal, Dennis L. Molfese 210 31$aTotowa, New Jersey:$cHumana Press,$d2005 210 4$dİ2005 215 $a1 online resource (XII, 560 pages) $cillustrations ;$ddigital file (PDF) 225 1 $aContemporary Clinical Neuroscience. 311 $a1-58829-312-2 311 $a1-61737-485-7 330 $aAttention deficit hyperactivity disorder (ADHD) is a common neurobehavioral disorder affecting 5?10% of children and adolescents and 3% of adults. Attention Deficit Hyperactivity Disorder: From Genes to Patients aims to provide a comp- hensive, state-of-the-art overview of the critical aspects of ADHD, and hopefully will serve as a quick and up-to-date reference source for professionals with an int- est in ADHD. The book is divided into three major areas that follow an historical survey. The first group of chapters deals with current theories on the pathophysiology of ADHD, and focuses on neurotransmitters and the contributions and validity of animal m- els. The second section emphasizes the evaluation and treatment of patients with ADHD, from the day-to-day approach by the clinical psychologist to the more sophisticated anatomical and functional imaging strategies that have emerged in the last decade. In addition, chapters dealing with specific impairments, such as those pertaining to reading, social interaction, and working memory, are also included for more detailed analysis of these important aspects and their respective contributions to global functioning. The third and final section provides an expanded review on the pharmacotherapy of ADHD and the appropriate methods for selection of specific drugs for individual patients based on drug kinetics and gene expression 410 0$aContemporary Clinical Neuroscience. 606 $aAttention-deficit hyperactivity disorder 606 $aChildren with attention-deficit hyperactivity disorder 606 $aPSYCHOLOGY$xPsychopathology$xAttention-Deficit Disorder (ADD-ADHD)$2bisacsh 610 1$aAtomoxetin 610 1$aMethylphenidat 610 1$ahyperactivity 610 1$aneuropsychology 615 0$aAttention-deficit hyperactivity disorder 615 0$aChildren with attention-deficit hyperactivity disorder 615 7$aPSYCHOLOGY$xPsychopathology$xAttention-Deficit Disorder (ADD-ADHD) 676 $a618.928589 702 $aGozal$b David 702 $aMolfese$b Dennis L 906 $aBOOK 912 $a9910702867803321 996 $aAttention deficit hyperactivity disorder$92875294 997 $aUNINA